Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a chronic, progressive disease of the pulmonary vasculature with a high morbidity and mortality. Its pathobiology involves at least three interacting pathways – prostacyclin (PGI(2)), endothelin, and nitric oxide (NO). Current treatments target these three pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Barst, Robyn J., Channick, Richard, Ivy, Dunbar, Goldstein, Brahm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401867/
https://www.ncbi.nlm.nih.gov/pubmed/22837854
http://dx.doi.org/10.4103/2045-8932.97589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401867/
https://www.ncbi.nlm.nih.gov/pubmed/22837854
http://dx.doi.org/10.4103/2045-8932.97589

Ejemplares similares